Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation.

Baden J, Lin CJ, Anfora AT, Beer J, Bisselou K, Bungo J, Corner AS, Danek T, Dickey J, Godsey JH, Johann DJ, Jones G, Karlin-Neumann G, Larson JL, Lee JSH, Liu L, Lopez Ramos D, Merriam D, Palomares M, Pena CE, Rathbun J, Rhodes K, Connolly Rohrbach JE, Saritas-Yildirim B, Sausen M, Zhang S, Leiman LC

Open source

DOI: 10.1200/po-25-00267
Published: 2026 Jan
Container: JCO precision oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/po-25-00267,
  title = {Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation.},
  author = {Baden J and Lin CJ and Anfora AT and Beer J and Bisselou K and Bungo J and Corner AS and Danek T and Dickey J and Godsey JH and Johann DJ and Jones G and Karlin-Neumann G and Larson JL and Lee JSH and Liu L and Lopez Ramos D and Merriam D and Palomares M and Pena CE and Rathbun J and Rhodes K and Connolly Rohrbach JE and Saritas-Yildirim B and Sausen M and Zhang S and Leiman LC},
  year = {2026},
  journal = {JCO precision oncology},
  doi = {10.1200/po-25-00267},
  url = {https://doi.org/10.1200/po-25-00267}
}

RIS

TY  - JOUR
TI  - Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation.
AU  - Baden J
AU  - Lin CJ
AU  - Anfora AT
AU  - Beer J
AU  - Bisselou K
AU  - Bungo J
AU  - Corner AS
AU  - Danek T
AU  - Dickey J
AU  - Godsey JH
AU  - Johann DJ
AU  - Jones G
AU  - Karlin-Neumann G
AU  - Larson JL
AU  - Lee JSH
AU  - Liu L
AU  - Lopez Ramos D
AU  - Merriam D
AU  - Palomares M
AU  - Pena CE
AU  - Rathbun J
AU  - Rhodes K
AU  - Connolly Rohrbach JE
AU  - Saritas-Yildirim B
AU  - Sausen M
AU  - Zhang S
AU  - Leiman LC
PY  - 2026
JO  - JCO precision oncology
DO  - 10.1200/po-25-00267
UR  - https://doi.org/10.1200/po-25-00267
ER  -

APA

J, B., CJ, L., AT, A., J, B., K, B., J, B., AS, C., T, D., J, D., JH, G., DJ, J., G, J., G, K., JL, L., JSH, L., L, L., D, L. R., D, M., M, P., CE, P., J, R., K, R., JE, C. R., B, S., M, S., S, Z., & LC, L. (2026). Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation.. JCO precision oncology. https://doi.org/10.1200/po-25-00267

Source records

pubmed · retrieved 2026-09-26T07:37:16.957Z